The present study showed that CAI, the specific calpain inhibitor, inhibited the vascular calcification in rats with hypercholesterolemia and that siRNA against calpain-1 reduced the calcium deposition in RVSMCs treated with oxLDL. The gene discussed is CAPN1; the disease is familial hypercholesterolemia.